Vertex Pharmaceuticals Share Price (VRTX.US)

Vertex Pharmaceuticals, Inc. is listed on the CBOE trading with ticker code VRTX.US. It has a market capitalisation of $114.63b, with approximately 253.81m shares in issue. Over the last year, Vertex Pharmaceuticals share price has been traded in a range of 144.96, hitting a high of 507.60, and a low of 362.64.

Vertex Pharmaceuticals is a global biotechnology company headquartered in Boston, Massachusetts. Founded in 1989, Vertex specialises in developing innovative therapies for serious diseases, with a strong focus on cystic fibrosis. The company’s groundbreaking treatments have significantly improved the lives of patients with this condition. Vertex is also engaged in research and development for other conditions, including sickle cell disease and muscular dystrophy. Committed to scientific excellence and patient care, Vertex invests heavily in cutting-edge research to discover and develop new medicines. The company’s dedication to transforming lives through innovative therapies has established it as a leader in the biotechnology industry